Knöringer P
Unfallchirurgie. 1986 Apr;12(2):81-92. doi: 10.1007/BF02588327.
Osteomyelitis in the skull region is encountered preferably as a postoperative, but also as a posttraumatic lesion, furthermore it occurs in case of infection of the paranasal sinuses or, rarely, as hematogenic metastasis. The routine treatment comprises a careful wound cleaning with excision of fistula, resection of the osteomyelitic bone and ablation of all purulent and devital tissues, eventually sanitation of an infected paranasal sinus. Between six and twelve months after the healing of the infection, the bone defect is closed by plastic surgery. In 1976, we have introduced Refobacin-Palacos R for the local treatment of the infection with simultaneous definitive closing of the bone defect in case of osteomyelitis of the skull. 44 patients have been treated since with this method. The rate of reinfection was 3% in osteomyelitis of the calotte without involvement of the sinuses and 25% in case of involvement of the frontal sinuses. A twofold method has been developed in order to reduce the relatively high frequency of reinfection in case of involvement of the frontal sinuses. The wound cleaning with revision of the frontal sinuses and parenteral administration of antibiotic drugs was performed as usual. An additional local treatment of the infected frontal sinuses was performed by implantation of Septopal chains which were removed ten to fourteen days later. During the same session the nasal excretory ducts were closed and the frontal sinuses largely filled up with muscle pieces together with a compound of spongiosa, fibrin, and antibiotic. The remaining bone gap was closed with Refobacin-Palacos R. A significantly decreased reinfection rate is anticipated with this twofold procedure, however, a clear statement is not yet possible due to the small number of cases and the relatively short follow-up period.
颅骨区域的骨髓炎多为术后发生,但也可由外伤引起,此外还可因鼻窦感染或极少见的血行转移所致。常规治疗包括仔细清创、切除瘘管、切除骨髓炎骨质并清除所有脓性和失活组织,必要时对感染的鼻窦进行清理。感染愈合后6至12个月,通过整形手术闭合骨缺损。1976年,我们引入了瑞呋新-帕拉科斯R用于颅骨骨髓炎感染的局部治疗,同时在有骨缺损时进行确定性闭合。自那时起,已有44例患者采用此方法治疗。在无鼻窦受累的颅骨骨髓炎中,再感染率为3%,而在额窦受累的情况下,再感染率为25%。为降低额窦受累时相对较高的再感染频率,我们开发了一种双重治疗方法。像往常一样进行清创并检查额窦,同时静脉注射抗生素。通过植入Septopal链对感染的额窦进行额外的局部治疗,10至14天后取出。在同一次手术中,封闭鼻排泄管,并用肌肉块以及海绵骨、纤维蛋白和抗生素的复合物大量填充额窦。剩余的骨间隙用瑞呋新-帕拉科斯R闭合。预计这种双重治疗方法可显著降低再感染率,但由于病例数量少且随访期相对较短,目前尚无法得出明确结论。